Skip to content
← Full study record

NCT00085735 · OUTCOME

Post-treatment Endocrine Function by CSI Group

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma · Source last updated 2026-06-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
uU/ml
Interval / dispersion
Standard Deviation
Time frame
Up to 3 years

What was measured

Post-treatment endocrine function was measured by laboratory assessment of the thyroid stimulating hormone (TSH). The mean TSH will be reported.

Analysis population: Only eligible \& evaluable pts 3-7 years of age were included. Pts with anaplastic histology or disseminated/excess residual disease were not evaluable (NE). 11 and 8 LDSCI and SDCSI pts were NE, respectively, leaving 116 vs 110 for this comparison. Of these, 89 LDSCI and 79 SDCSI pts had post-treatment TSH values available and were included.

Groups in this outcome

Low-dose Craniospinal Radiation (LDSCI)

Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the LDCSI arms (Treatment Arms I or II) and with a post-treatment TSH value.

Standard-dose Craniospinal Radiation (SDCSI)

Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the SDCSI arms (Treatment Arms III or IV) and with a post-treatment TSH value.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Low-dose Craniospinal Radiation (LDSCI)89
Standard-dose Craniospinal Radiation (SDCSI)79

Reported measurements

Source class 1
Values in uU/ml · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Low-dose Craniospinal Radiation (LDSCI)5.35.6Not reportedNot reportedNot reported
Standard-dose Craniospinal Radiation (SDCSI)6.15.3Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        5.6
        value
        5.3
      2. group Id
        OG001
        spread
        5.3
        value
        6.1
denoms
  1. counts
    1. group Id
      OG000
      value
      89
    2. group Id
      OG001
      value
      79
    units
    Participants
description
Post-treatment endocrine function was measured by laboratory assessment of the thyroid stimulating hormone (TSH). The mean TSH will be reported.
dispersion Type
Standard Deviation
groups
  1. description
    Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the LDCSI arms (Treatment Arms I or II) and with a post-treatment TSH value.
    id
    OG000
    title
    Low-dose Craniospinal Radiation (LDSCI)
  2. description
    Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the SDCSI arms (Treatment Arms III or IV) and with a post-treatment TSH value.
    id
    OG001
    title
    Standard-dose Craniospinal Radiation (SDCSI)
param Type
MEAN
population Description
Only eligible \& evaluable pts 3-7 years of age were included. Pts with anaplastic histology or disseminated/excess residual disease were not evaluable (NE). 11 and 8 LDSCI and SDCSI pts were NE, respectively, leaving 116 vs 110 for this comparison. Of these, 89 LDSCI and 79 SDCSI pts had post-treatment TSH values available and were included.
reporting Status
POSTED
time Frame
Up to 3 years
title
Post-treatment Endocrine Function by CSI Group
type
SECONDARY
unit Of Measure
uU/ml

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice